Scindeks Assistant SCIndeks Assistant
Vol. 76 No. 3 (2019)

Ten years of consumption of anti-glaucoma medicaments in Serbia

DOI: 10.2298/VSP190102016K
Sanja Kocic
Department of Social medicine, Faculty of Medical Sciences, University of Kragujevac
Snezana Radovanovic
Department of Social medicine, Faculty of Medical Sciences, University of Kragujevac
Katarina Mirjana Janicijevic
Department of Social medicine, Faculty of Medical Sciences, University of Kragujevac
Svetlana Radevic
Department of Social medicine, Faculty of Medical Sciences, University of Kragujevac
Natasa Mihailovic
Department of Social medicine, Institute for Public Health Kragujevac
Marija Sekulic
Department of Hygiene and Ecology, Faculty of Medical Sciences, University of Kragujevac
Aleksandra Eger
Euro-Medic, Private Health Centre, Belgrade
Mirjana Andreja Janicijevic Petrovic
Clinic of ophthalmology Clinical Centre Kragujevac in Kragujevac
PDF

Published

2021-02-10

Section

Letter to the editor

How to Cite

1.
Kocic S, Radovanovic S, Janicijevic KM, Radevic S, Mihailovic N, Sekulic M, et al. Ten years of consumption of anti-glaucoma medicaments in Serbia. Vojnosanit Pregl [Internet]. 2021 Feb. 10 [cited 2026 Sep. 20];76(3). Available from: https://test.aseestant.ceon.rs/index.php/vsp/article/view/20086
ACS APA ABNT Chicago Harvard IEEE Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
DOI: 10.2298/VSP190102016K

References

REFERENCES

Gupta D, Chen PP. Glaucoma. Am Fam Physician 2016; 93(8): 668–74.

Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol 2013; 156(4): 724–30.

Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90(3): 262–7.

National Institute for Health and Care Excellence. Glaucoma: diagnosis and management. London: National Institute for Health and Care Excellence (UK); 2017.

Mantravadi AV, Vadhar N. Glaucoma. Prim Care 2015; 42(3): 437–49.

Varma R, Lee PP, Goldberg I, Kotak S. An Assessment of the Health and Economic Burdens of Glaucoma. Am J Ophthal-mol 2011; 152(4): 515–22.

Holló G, Hommer A. Delivery of Glaucoma Care Committee of the European Glaucoma Society. The status of glaucoma diagnostics and care in Europe in 2015: European survey. Eur J Ophthalmol 2016; 26(3): 216–20.

Moyer VA. U.S. Preventive Services Task Force. Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2013; 159(7): 484–9.

American Academy of Ophthalmology. Preferred Practice Pattern - Primary Open-Angle Glaucoma. San Francisco, CA: Elsevier Inc; 2016.

Lee JW, Wong BK, Yick DW, Wong IY, Yuen CY, Lai JS. Primary acute angle closure: Long-term clinical outcomes over a 10-year period in the Chinese population. Int Ophthalmol 2014; 34(2): 165–9.

Kuo YS, Liu CJ, Cheng HC, Chen MJ, Chen WT, Ko YC. Impact of socioeconomic status on vision-related quality of life in primary open-angle glaucoma. Eye (Lond) 2017; 31(10): 1480–7.

Stillitano IG, Lima MG, Ribeiro MP, Cabral J, Brandt CT. Eco-nomic impact of eye drop cost in glaucoma treatment. Arq Bras Oftalmol 2005; 68(1): 79–84. Portuguese

Podatki o zdravilih in medicinskih pripomočkih - Zdravila v humani medicini. Ljubljana: Javna agencija Republike Slovenie za zdravila in medicinske pripomočke. Available from: https://www.jazmp.si/seznami/#c713.

Sakshaug S, Strøm H, Berg C, Blix HS, Litleskare I, Granum T. Legemiddelforbruket i Norge 2011-2015, Drug Consumption in Norway 2011-2015. Oslo: Norwegian Institute of Public Health; 2016 (Norwegian)

European Glaucoma Society Terminology and Guidelines for Glaucoma. 4th ed. Chapter 3: Treatment principles and op-tions Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3. Treatment principles and options. Br J Ophthalmol 2017; 101(6): 130–95.